학술논문
Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management
Document Type
article
Author
Daniel TT Chong; Felicita Andreotti; Peter Verhamme; Jamshed J Dalal; Noppacharn Uaprasert; Chun-Chieh Wang; Young Keun On; Yi-Heng Li; Jun Jiang; Koji Hasegawa; Khalid Almuti; Rong Bai; Sidney TH Lo; Rungroj Krittayaphong; Lai Heng Lee; David KL Quek; Sofian Johar; Swee-Chong Seow; Christopher J Hammett; Jack WC Tan
Source
European Cardiology Review, Vol 16, Iss , Pp - (2021)
Subject
Language
English
ISSN
1758-3764
1758-3756
1758-3756
Abstract
The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists (VKA) for preventing thromboembolic events in patients with AF. The Asian Pacific Society of Cardiology developed this consensus statement to guide physicians in the management of AF in Asian populations. Statements were developed by an expert consensus panel who reviewed the available data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting 17 statements provide guidance on the assessment of stroke risk of AF patients in the region, the appropriate use of DOACs in these patients, as well as the concomitant use of DOACs and antiplatelets, and the transition to DOACs from VKAs and vice versa. The periprocedural management of patients on DOAC therapy and the management of patients with bleeding while on DOACs are also discussed.